After his annual physical, a middle-age man is told that his PSA level has jumped to 2.3 after having been stable for years at 1.5. Should he be alarmed?
Maybe and maybe not. The PSA test, as few men older than 40 need to be told, is widely used as a screening tool for prostate cancer. But the test is controversial, and for good reason.
For one thing, the cancer itself is highly variable. As many as 15 percent of 50-year-old men will be given diagnoses of prostate cancer over the next 30 years. But 1.4 percent will die of the disease in that time, a 10-fold difference that shows that the cancer is usually not fatal. By age 85, more than three-fourths of men have evidence of prostate cancer; many have lived with the disease for more than 10 years.
PHOTO: NY TIMES NEWS SERVICE
In addition, PSA levels often fluctuate as much as 30 percent for unknown reasons and can increase for reasons other than cancer, challenging physicians who have to determine how to proceed when a man's PSA level goes up.
"There's a lot of background noise" associated with PSA testing, said Peter Scardino, chief of urology at the Memorial Sloan-Kettering Cancer Center in New York and author of Dr. Peter Scardino's Prostate Book (Penguin, 2005). Still, as evidence of the value of the test, he noted that the US has since 1992 recorded a 30 percent decline in age-specific mortality from prostate cancer, "despite no dramatic new therapy for advanced disease."
PSA stands for prostate-specific antigen, a substance produced only by the prostate gland and found in the ejaculate. Its purpose is to liquefy the semen to release sperm, freeing them to fertilize an egg. The PSA level, measured in nanograms per milliliter of blood, reflects how much of this antigen is being produced and released into the bloodstream. The larger a man's prostate, the more PSA is produced, which makes the test very confusing in older men with benign enlargement of this gland.
Aside from cancer and prostatic growth with age, factors that can change PSA measurements include inflammation or infection of the prostate; a decline in testosterone levels or the drug finasteride, taken for hair loss, both of which lower the PSA; and variations in laboratory assays and in the inherent biology of a person. Biological variability can result in as much as a 15 percent difference between readings, and in nearly half of men with an abnormal PSA, the test will normalize in one to four years without any treatment.
But H. Ballentine Carter, a urologist at the Johns Hopkins School of Medicine, notes that no significant changes in PSA result from recent sexual intercourse or ejaculation, a digital rectal examination or riding a bicycle. "Even long-distance bikers do not have prostate trauma" that causes their PSA to increase, Carter said.
Current US guidelines recommend that all men have an annual PSA test starting at age 50 and that biopsies be conducted if the level exceeds four or if a "significant rise" occurs between two tests. The guidelines also suggest limiting screening to men with more than a 10-year life expectancy.
This approach has resulted in many biopsies in men who did not have cancer — about 70 percent of those with elevated PSAs are cancer free — and debilitating prostate surgery in men with cancers that would never have become a threat in their remaining years of life.
Based on recent studies, the American Urological Association will soon release revised guidelines that, experts hope, will reduce unnecessary biopsies and prostate surgeries, which even in the best hands can leave a man impotent and incontinent. The revised guidelines are expected to reduce the cost of screening, the cost per life saved and overall deaths from prostate cancer.
The new guidelines will no longer rely on a single reading. Rather, they will suggest that doctors focus on changes in levels over time. They will also suggest that testing start at 40 to obtain a baseline measurement, with the test repeated at 45 and 50, after which it should be given annually until 70.
"If a 70-year-old man has a PSA history that hasn't changed over the years, maybe he doesn't need further testing," Carter suggested. "PSA testing of men over 70 is not rational."
He pointed to a Scandinavian study showing that among men older than 65, to prevent one death from prostate cancer over 10 years, 330 men would have to have prostate surgery.
"This has created a huge dilemma in urology," Carter said. "We don't want to miss the possibility of a life-threatening disease, but we end up diagnosing and treating disease that would never have caused harm."
The new guidelines will lower the PSA level at which a biopsy should be considered, because, as Carter put it, "there's no level below which we can tell a man he doesn't have prostate cancer or life-threatening prostate cancer."
As one important trial showed, among men with a very low PSA — that is, a reading below the current cutoff of four — biopsies found that 15 percent had prostate cancer. Among that 15 percent, Carter said, 15 percent had high-grade, potentially life-threatening cancers. That means that 2.25 percent of the total number of men with a PSA less than four had life-threatening cancers.
But, he added, "If we biopsied every man with a PSA below four, we'd be looking at a sea of cancers that would never grow to be life threatening."
These facts and the results of a recent study by Carter, among others, indicated that rather than acting on the basis of a single PSA test, the rate of change in levels over time is a better indicator of who might have a serious cancer. This rate, known as PSA velocity, will be part of the new guidelines, which will suggest that in men with low readings, doctors consider the changes in levels over the course of three measurements.
"We need at least 1 1/2 to 2 years' worth of data" to make a meaningful judgment about how to proceed, Carter said.
He explained that in men with an initially high level — say 10 or higher — velocity is not an issue. For them, if other factors like prostate infection are not the cause of the high level, a biopsy is in order. But in men with a PSA from zero to four, knowing the velocity of changes can add useful information, he said.
Another approach to assessing the meaning of a PSA reading is to analyze how much antigen is traveling free in the blood and how much is bound to a companion protein, Scardino suggested. If more than 25 percent of the PSA is free, chances are that it is being produced by a benignly enlarged prostate. The lower the amount of free PSA, the more likely cancer is the cause and the more likely the disease is aggressive, requiring treatment, according to Patrick Walsh, a Johns Hopkins urologist and the author of Dr. Patrick Walsh's Guide to Surviving Prostate Cancer.
In late October of 1873 the government of Japan decided against sending a military expedition to Korea to force that nation to open trade relations. Across the government supporters of the expedition resigned immediately. The spectacle of revolt by disaffected samurai began to loom over Japanese politics. In January of 1874 disaffected samurai attacked a senior minister in Tokyo. A month later, a group of pro-Korea expedition and anti-foreign elements from Saga prefecture in Kyushu revolted, driven in part by high food prices stemming from poor harvests. Their leader, according to Edward Drea’s classic Japan’s Imperial Army, was a samurai
Approaching her mid-30s, Xiong Yidan reckons that most of her friends are on to their second or even third babies. But Xiong has more than a dozen. There is Lucky, the street dog from Bangkok who jumped into a taxi with her and never left. There is Sophie and Ben, sibling geese, who honk from morning to night. Boop and Pan, both goats, are romantically involved. Dumpling the hedgehog enjoys a belly rub from time to time. The list goes on. Xiong nurtures her brood from her 8,000 square meter farm in Chiang Dao, a mountainous district in northern Thailand’s
Located down a sideroad in old Wanhua District (萬華區), Waley Art (水谷藝術) has an established reputation for curating some of the more provocative indie art exhibitions in Taipei. And this month is no exception. Beyond the innocuous facade of a shophouse, the full three stories of the gallery space (including the basement) have been taken over by photographs, installation videos and abstract images courtesy of two creatives who hail from the opposite ends of the earth, Taiwan’s Hsu Yi-ting (許懿婷) and Germany’s Benjamin Janzen. “In 2019, I had an art residency in Europe,” Hsu says. “I met Benjamin in the lobby
April 22 to April 28 The true identity of the mastermind behind the Demon Gang (魔鬼黨) was undoubtedly on the minds of countless schoolchildren in late 1958. In the days leading up to the big reveal, more than 10,000 guesses were sent to Ta Hwa Publishing Co (大華文化社) for a chance to win prizes. The smash success of the comic series Great Battle Against the Demon Gang (大戰魔鬼黨) came as a surprise to author Yeh Hung-chia (葉宏甲), who had long given up on his dream after being jailed for 10 months in 1947 over political cartoons. Protagonist